West Pharmaceutical Services, Inc. (WST)
Evaluation: Based on all recent filings, financial statements, and news.
See full evaluationAsk a question about West Pharmaceutical Services, Inc. (WST)
Go deeper and ask any question about WST
Company Performance
Current Price
as of Oct 04, 2024$296.50
P/E Ratio
42.17
Market Cap
$21.51B
Description
West Pharmaceutical Services, Inc. manufactures and markets pharmaceuticals, biologics, vaccines and consumer healthcare products. It operates through the following business segments: Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers proprietary packaging, containment and drug delivery products, along with analytical lab services, to biologic, generic and pharmaceutical drug customers. The Contract-Manufactured Products segment serves as a fully integrated business, focused on the design, manufacture and automated assembly of complex devices, primarily for pharmaceutical, diagnostic, and medical device customers. The company was founded by Herman O. West on July 27, 1923 and is headquartered in Exton, PA.
Metrics
Overview
- HQExton, PA
- SectorHealth Technology
- IndustryMedical Specialties
- TickerWST
- Price$296.5-0.27%
Trading Information
- Market Cap$21.51B
- Float99.41%
- Average Daily Volume (1m)404,838
- Average Daily Volume (3m)548,752
- EPS$7.11
Company
- Revenue$2.88B
- Rev Growth (1yr)-6.92%
- Net Income$111.30M
- Gross Margin32.95%
- EBITDA Margin24.17%
- EBITDA$169.70M
- EV$24.14B
- EV/Revenue8.39
- P/E42.17
- P/S7.60